| Typ : |
Zeitung |
| Internet-Link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3804 |
|
| Forschungsgruppen : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
| Autoren : |
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
| Titel : |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. |
| Veröffentlichung : |
Int J Pharm Compound ; 18, 2 : 169-174. 2014 |
|
| Niveau von Beweisen : |
|
| Physikalische Stabilität : |
|
| Chemische Stabilität : |
|
| Andere Verfahren : |
|
| Kommentare : |
|
Molekülverzeichnis
 Valsartan
|
 |
 |
 |
 |
400 mg
Valzan® (Pharmacare PLC) |
| Xanthan |
20 mg |
| Hydroxypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| Bananengeschmack |
20 mg |
| Natriumphosphat |
80 mg |
| Titandioxid |
1 mg |
| Erdbeergeschmack |
110 mg |
| Saccharose |
22,04 g |
| Gereinigtes Wasser |
>> 25 mL |
|
23-27°C |
 |
| 30 |
 |
|
|
|
|
|
400 mg
Valzan® (Pharmacare PLC) |
| Xanthan |
20 mg |
| Hydroxypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| Bananengeschmack |
20 mg |
| Natriumphosphat |
80 mg |
| Titandioxid |
1 mg |
| Erdbeergeschmack |
110 mg |
| Saccharose |
22,04 g |
| Gereinigtes Wasser |
>> 25 mL |
|
38-42°C |
|
| 30 |
|
|
|
|
|
